Finzony

Thyrocare Technologies Limited

THYROCARE Healthcare
₹ 362.1
-1.90%

Live Market Data

Market Cap₹ 5,763 Cr.
Current Price₹ 362.1
High / Low₹536.6667 / 219.56667
Stock P/E41.6
Book Value₹33.6
Dividend Yield2.53 %
ROCE0.0 %
ROE0.0 %

About Company

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Industry Segment

Diagnostics & Research

Price Chart

Loading Chart...

Technical Analysis

Technical Outlook

Short TermBearish
Mid TermBearish
Long TermNeutral
Resistance₹530.6333618164062
Support₹226.5500030517578

Valuation Check

Fair Value Assessment
Fair Value

Research Reports

No recent reports available.

Peer Comparison

Related Sector
CompanyPriceP/EM.Cap (Cr)ROE %
DR. LAL PATH LABS LTD.
LALPATHLAB
₹1,342.442.3622,415-
METROPOLIS HEALTHCARE LTD
METROPOLIS
₹1,879.858.149,743-
NARAYANA HRUDAYALAYA LTD.
NH
₹1,69544.2834,425-
SYNGENE INTERNATIONAL LTD
SYNGENE
₹420.5548.0116,903-
J B CHEMICALS AND PHARMA
JBCHEPHARM
₹2,10044.1633,717-

Quarterly Results

ParticularsDec 25Jun 25Dec 24Jun 24Jan 70
Total Revenue (Cr)195.53193.03165.9200
Net Income (Cr)29.0138.9819.1100
EPS (₹)1.822.451.1503.02

Annual Profit & Loss

Particulars20252024202320221970
Total Revenue (Cr)687.35571.88526.67588.860
Operating Exp (Cr)360.4312.47278.82217.310
Net Income (Cr)91.5170.7664.49176.140
EPS (₹)5.764.464.0511.10

Balance Sheet

ParticularsDec 25Jun 25Dec 24Jun 24Jan 70
Total Assets (Cr)-----
Total Liabilities (Cr)-----
Total Equity (Cr)-----

Key Ratios Fundamentals

Valuation

P/E Ratio (TTM)
41.57
Forward P/E
30.43
PEG Ratio
-
Price / Book
10.78
EV / EBITDA
23.91

Profitability

ROE
-
ROA
-
Profit Margin
17.35%
Operating Margin
18.51%

Liquidity & Debt

Current Ratio
-
Quick Ratio
-
Debt / Equity
4.62
Total Cash (Cr)
192.41

Price Statistics

Beta
0.19
52W High
536.67
52W Low
219.57
Dividend Yield
2.53%

Pattern Unavailable

Detailed shareholding breakdown is not currently provided by the exchange.